Active

Share Your Experience of Type 2 Diabetes Medications

Massive Wave Research is conducting an in-person market research study in Manchester, UK, to better understand the experiences of people living with Type 2 Diabetes (T2D) who use injectable treatments. Your insights will help improve future diabetes care and treatment options.

Who Can Take Part?
We are looking for adults (aged 18–75) living in the UK who:

  • Have been diagnosed with Type 2 Diabetes
  • Are currently using injectable medication for diabetes management


What Does Participation Involve?

A 90-minute in-person interview in central Manchester
Bring your injection device(s) if comfortable.

Why Your Voice Matters?
Your feedback will help shape better solutions for people living with T2D, ensuring treatments and devices meet real-world needs.

MWRH070_13th_Jan_2026_Active

Adverse event / safety data

We are required to pass on to the pharmaceutical company sponsoring the study details of adverse events and/or other safety information - hereinafter referred to as safety information - that are mentioned during this study. Although what you say will be treated in confidence, should you mention safety information during the study, we will need to report it even if you have already reported it to the company or regulatory authorities.

In relation to reporting safety information situations we need to know if you are willing to waive the confidentiality given to you under the Market Research Codes of Conduct. In the event that you waive confidentiality in relation to safety information reporting, any personal data provided during the reporting will be processed as follows:

Any personal data in relation to the safety information reported will be forwarded to the project sponsor; and The project sponsor will record any safety information, including personal data received in the sponsor’s global database, in the interests of patient safety and in compliance with all applicable global laws and regulations;

During the reporting of safety information, the project sponsor will not disclose such personal data to any un-associated third parties, with the exception of any disclosures required by applicable law, regulation, or the order of a competent authority.

Do you agree to waive the confidentiality given to you under the Market Research Codes of Conduct in relation to any safety information you report to us? If you agree, your contact details will be forwarded to the sponsor's Safety department for the express and sole purpose of follow-up of such report(s). Details of safety information may be reported to regulatory authorities along with your personal data. All other information provided by you in this study will remain confidential.

If you prefer to preserve the confidentiality of this information, please select 'I do not agree'. If you do so, you can still participate in this survey.

Do you agree to share your details?
Have you been diagnosed with diabetes?
Please confirm which type of Diabetes you have been diagnosed with:
Are you taking injectable medication to treat your diabetes?
Please confirm which type(s) of medication you use?
Please confirm which type(s) of insulin you use?
How are you receiving medication?
Do you work in any of the following?
Have you participated in any market research in the past 6 months?
Have you participated in any market research in the past 6 months related to injection devices?
Please confirm you consent to our client and the research team listening/viewing the interviews live for analysis purposes?
Thank you for applying to our study! If you pass the initial screening phase, a member of our team will be in touch either via phone or email to go through the remaining screening questions and book you in. Do you agree to be contacted?